Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concise review: role of DEK in stem/progenitor cell biology.
Broxmeyer HE, Mor-Vaknin N, Kappes F, Legendre M, Saha AK, Ou X, O'Leary H, Capitano M, Cooper S, Markovitz DM. Broxmeyer HE, et al. Among authors: legendre m. Stem Cells. 2013 Aug;31(8):1447-53. doi: 10.1002/stem.1443. Stem Cells. 2013. PMID: 23733396 Free PMC article. Review.
DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.
Broxmeyer HE, Kappes F, Mor-Vaknin N, Legendre M, Kinzfogl J, Cooper S, Hangoc G, Markovitz DM. Broxmeyer HE, et al. Among authors: legendre m. Stem Cells Dev. 2012 Jun 10;21(9):1449-54. doi: 10.1089/scd.2011.0451. Epub 2011 Oct 27. Stem Cells Dev. 2012. PMID: 21943234 Free PMC article.
Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML, Mor-Vaknin N, Saha AK, Cooper S, Legendre M, Guo H, Contreras-Galindo R, Kappes F, Sartor MA, Lee CT, Huang X, Markovitz DM, Broxmeyer HE. Capitano ML, et al. Among authors: legendre m. J Clin Invest. 2019 May 20;129(6):2555-2570. doi: 10.1172/JCI127460. eCollection 2019 May 20. J Clin Invest. 2019. PMID: 31107242 Free PMC article.
The DEK nuclear autoantigen is a secreted chemotactic factor.
Mor-Vaknin N, Punturieri A, Sitwala K, Faulkner N, Legendre M, Khodadoust MS, Kappes F, Ruth JH, Koch A, Glass D, Petruzzelli L, Adams BS, Markovitz DM. Mor-Vaknin N, et al. Among authors: legendre m. Mol Cell Biol. 2006 Dec;26(24):9484-96. doi: 10.1128/MCB.01030-06. Epub 2006 Oct 9. Mol Cell Biol. 2006. PMID: 17030615 Free PMC article.
Intercellular trafficking of the nuclear oncoprotein DEK.
Saha AK, Kappes F, Mundade A, Deutzmann A, Rosmarin DM, Legendre M, Chatain N, Al-Obaidi Z, Adams BS, Ploegh HL, Ferrando-May E, Mor-Vaknin N, Markovitz DM. Saha AK, et al. Among authors: legendre m. Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6847-52. doi: 10.1073/pnas.1220751110. Epub 2013 Apr 8. Proc Natl Acad Sci U S A. 2013. PMID: 23569252 Free PMC article.
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, Koch AE, Fox DA, Engelke DR, Kaplan MJ, Markovitz DM. Mor-Vaknin N, et al. Among authors: legendre m. Nat Commun. 2017 Feb 6;8:14252. doi: 10.1038/ncomms14252. Nat Commun. 2017. PMID: 28165452 Free PMC article.
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
Mor-Vaknin N, Rivas M, Legendre M, Mohan S, Yuanfan Y, Mau T, Johnson A, Huang B, Zhao L, Kimura Y, Spalding SJ, Morris PW, Gottlieb BS, Onel K, Olson JC, Edelheit BS, Shishov M, Jung LK, Cassidy EA, Prahalad S, Passo MH, Beukelman T, Mehta J, Giannini EH, Adams BS, Lovell DJ, Markovitz DM. Mor-Vaknin N, et al. Among authors: legendre m. Arthritis Rheumatol. 2018 Apr;70(4):594-605. doi: 10.1002/art.40404. Epub 2018 Feb 22. Arthritis Rheumatol. 2018. PMID: 29287303 Free PMC article.
429 results